Cargando…

Prediction of Poor Prognosis in Breast Cancer Patients Based on MicroRNA-21 Expression: A Meta-Analysis

BACKGROUND: MicroRNA-21 (miRNA-21 or miR-21) may act as a prognostic biomarker of cancer. However, the available evidence is controversial. Therefore, the present meta-analysis summarizes this evidence and evaluates the prognostic role of this gene in breast cancer. METHODS: The meta-analysis was co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanyan, Zhang, Yujie, Pan, Chi, Ma, Feixia, Zhang, Suzhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338069/ https://www.ncbi.nlm.nih.gov/pubmed/25706383 http://dx.doi.org/10.1371/journal.pone.0118647

Ejemplares similares

Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: a meta-analysis
por: Wang, Yanyan, et al.
Publicado: (2020)

MicroRNA-183 and microRNA-141 are potential risk factors for poor prognosis in patients with nasopharyngeal carcinoma
por: Lian, Junsheng, et al.
Publicado: (2019)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer
por: Liu, Huiya, et al.
Publicado: (2019)

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
por: Lu, Shengkui, et al.
Publicado: (2012)

MicroRNA-623 inhibits tumor progression and is a predictor of poor prognosis of breast cancer
por: Wang, Chunfeng, et al.
Publicado: (2020)

Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016)

High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer
por: Sim, Jongmin, et al.
Publicado: (2015)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis
por: Chen, Zexin, et al.
Publicado: (2016)

Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis
por: SONG, JIANNING, et al.
Publicado: (2013)

High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma
por: Wang, Wen-yao, et al.
Publicado: (2014)

MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis
por: Hui, Chang, et al.
Publicado: (2012)

MicroRNA-21 facilitates osteoblast activity
por: Oka, Shunichi, et al.
Publicado: (2020)

The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis
por: Zhang, Wei, et al.
Publicado: (2020)

Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
por: Yang, Huiqiong, et al.
Publicado: (2018)

MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis
por: Zhou, Hongxing, et al.
Publicado: (2019)

Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer
por: Zhang, Jia-kui, et al.
Publicado: (2017)

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014)

Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer
por: Mokutani, Yukako, et al.
Publicado: (2016)

Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
por: Yi, Xiuling, et al.
Publicado: (2020)

Decreased Serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis
por: Liu, Yiwen, et al.
Publicado: (2019)

Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma
por: Liang, Shaoqiang, et al.
Publicado: (2016)

Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia
por: Bai, Jin, et al.
Publicado: (2012)

Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma
por: Song, Qian, et al.
Publicado: (2019)

Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
por: Zeng, Zhihao, et al.
Publicado: (2017)

Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma
por: ElKashef, Sabrin Mohamed Mohamed Abd Elhamed, et al.
Publicado: (2020)

Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis
por: Zhang, Huihui, et al.
Publicado: (2014)

Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients
por: Liu, Binghui, et al.
Publicado: (2021)

The MicroRNA-21 in Autoimmune Diseases
por: Wang, Shaowen, et al.
Publicado: (2016)

MicroRNA miR-497 is closely associated with poor prognosis in patients with cerebral ischemic stroke
por: Zhong, Changyang, et al.
Publicado: (2021)

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
por: Si, Haiyan, et al.
Publicado: (2012)

A novel six-microRNA-based model to improve prognosis prediction of breast cancer
por: Lai, Jianguo, et al.
Publicado: (2019)

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer
por: Shen, Shu-na, et al.
Publicado: (2013)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
por: Jiang, Wei, et al.
Publicado: (2017)

Serum levels of microRNA-21 and microRNA-10a can predict long-term prognosis in laryngeal cancer patients: a multicenter study
por: Gao, Shan, et al.
Publicado: (2020)

SNPs within microRNA binding sites and the prognosis of breast cancer
por: Zhang, Liwen, et al.
Publicado: (2021)

Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer
por: Yang, Yao, et al.
Publicado: (2014)

microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
por: Park, Sunyoung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tmjbqdrgpaard80ke97p0v9tch